18F-Fluorodeoxyglucose positron emission tomography for the assessment of myositis: A case series

N. Pipitone, A. Versari, G. Zuccoli, G. Levrini, P. MacChioni, G. Bajocchi, C. Salvarani

Research output: Contribution to journalArticlepeer-review

Abstract

Objective. To establish whether 18FFluorodeoxyglucose (FDG) positron emission computerised tomography (FDG-PET/CT) might reveal active disease in patients with myositis. Methods. We studied 12 patients with active myositis (2 polymyositis, 10 dermatomyositis). The controls consisted of 14 randomly chosen subjects without muscle disease. FDG uptake was expressed as the ratio of maximum proximal muscle to liver standardised uptake value. Magnetic resonance of the thigh and pelvic floor muscles was performed on a 1.0 or 1.5T scanner using a surface coil. Oedema (1= present, 0=absent) was assessed by fat suppressed sequences in 17 muscles and a score (0-17) calculated by adding the separate scores. Muscle strength was evaluated in 12 muscle groups by manual muscle test and graded according to the extended Medical Research Council scale (0-5). Results. FDG uptake in proximal muscles was significantly higher in patients with myositis (median 0.58, interquartile range 0.52) than in those without (median 0.30, interquartile range 0.09; p

Original languageEnglish
Pages (from-to)570-573
Number of pages4
JournalClinical and Experimental Rheumatology
Volume30
Issue number4
Publication statusPublished - Jul 2012

Keywords

  • Dermatomyositis
  • Magnetic resonance imaging
  • Myositis
  • Polymyositis
  • Positron emission tomography

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy

Fingerprint Dive into the research topics of '<sup>18</sup>F-Fluorodeoxyglucose positron emission tomography for the assessment of myositis: A case series'. Together they form a unique fingerprint.

Cite this